Lysine malonylation is elevated in type 2 diabetic mouse models and enriched in metabolic associated proteins

Molecular and Cellular Proteomics

Volumn 14, Issue 1, 2015, Pages 227-236

  Du, Yipeng ^a   Cai, Tanxi ^a,c   Li, Tingting ^b   Xue, Peng ^a   Zhou, Bo ^a,c   He, Xiaolong ^a,c   Wei, Peng ^a,c   Liu, Pingsheng ^a   Yang, Fuquan ^a   Wei, Taotao ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; LYSINE; PROTEIN;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; DB/DB MOUSE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; IMMUNOPRECIPITATION; LYSINE MALONYLATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN PROCESSING; PROTEOMICS; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DISEASE MODEL; LIVER; METABOLISM; OBESITY;

EUKARYOTA; MUS; PROKARYOTA;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; LIVER; LYSINE; MICE, INBRED C57BL; OBESITY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 84920403976     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.041947     Document Type: Article

References (36)

1. Nussinov, R., Tsai, C. J., Xin, F., and Radivojac, P. (2012) Allosteric post-translational modification codes. Trends Biochem. Sci. 37, 447-455
2. Walsh, C. T., Garneau-Tsodikova, S., and Gatto, G. J., Jr. (2005) Protein posttranslational modifications: the chemistry of proteome diversifications. Angew Chem. Int. Ed. Engl. 44, 7342-7372
3. Strahl, B. D., and Allis, C. D. (2000) The language of covalent histone modifications. Nature 403, 41-45
4. Lu, C. T., Huang, K. Y., Su, M. G., Lee, T. Y., Bretana, N. A., Chang, W. C., Chen, Y. J., Chen, Y. J., and Huang, H. D. (2013) DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications. Nucleic Acids Res. 41, D295-D305
5. Khoury, G. A., Baliban, R. C., and Floudas, C. A. (2011) Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database. Sci. Rep. 1, 90 DOI:10.1038/srep00090
6. Peng, C., Lu, Z., Xie, Z., Cheng, Z., Chen, Y., Tan, M., Luo, H., Zhang, Y., He, W., Yang, K., Zwaans, B. M., Tishkoff, D., Ho, L., Lombard, D., He, T. C., Dai, J., Verdin, E., Ye, Y., and Zhao, Y. (2011) The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell Proteomics 10, M111 012658
7. Zhang, Z., Tan, M., Xie, Z., Dai, L., Chen, Y., and Zhao, Y. (2011) Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 7, 58-63
8. Chen, Y., Sprung, R., Tang, Y., Ball, H., Sangras, B., Kim, S. C., Falck, J. R., Peng, J., Gu, W., and Zhao, Y. (2007) Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell Proteomics 6, 812-819
9. Cheng, Z., Tang, Y., Chen, Y., Kim, S., Liu, H., Li, S. S., Gu, W., and Zhao, Y. (2009) Molecular characterization of propionyllysines in nonhistone proteins. Mol. Cell Proteomics 8, 45-52
10. Tan, M., Luo, H., Lee, S., Jin, F., Yang, J. S., Montellier, E., Buchou, T., Cheng, Z., Rousseaux, S., Rajagopal, N., Lu, Z., Ye, Z., Zhu, Q., Wysocka, J., Ye, Y., Khochbin, S., Ren, B., and Zhao, Y. (2011) Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146, 1016-1028
11. Bao, X., Zhao, Q., Yang, T., Fung, Y. M., and Li, X. D. (2013) A chemical probe for lysine malonylation. Angew Chem. Int. Ed. Engl. 52, 4883-4886
12. Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., and Olefsky, J. M. (2006) Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277-2285
13. Zhao, Z., Lee, Y. J., Kim, S. K., Kim, H. J., Shim, W. S., Ahn, C. W., Lee, H. C., Cha, B. S., and Ma, Z. A. (2009) Rosiglitazone and fenofibrate improve insulin sensitivity of pre-diabetic OLETF rats by reducing malonyl-CoA levels in the liver and skeletal muscle. Life Sci. 84, 688-695
14. An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., and Newgard, C. B. (2004) Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver, and whole-animal insulin resistance. Nat. Med. 10, 268-274
15. Chen, X., Cui, Z., Wei, S., Hou, J., Xie, Z., Peng, X., Li, J., Cai, T., Hang, H., and Yang, F. (2013) Chronic high glucose induced INS-1beta cell mito-chondrial dysfunction: a comparative mitochondrial proteome with SILAC. Proteomics 13, 3030-3039
16. Jiang, P., Huang, Z., Zhao, H., and Wei, T. (2013) Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease. Biochem. Biophys. Res. Commun. 433, 408-414
17. Wagner, G. R., and Payne, R. M. (2013) Widespread and enzyme-independent Nepsilon-acetylation and Nepsilon-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 288, 29036-29045
18. Santamaria, R., Esposito, G., Vitagliano, L., Race, V., Paglionico, I., Zancan, L., Zagari, A., and Salvatore, F. (2000) Functional and molecular modeling studies of two hereditary fructose intolerance-causing mutations at arginine 303 in human liver aldolase. Biochem. J. 350, 823-828
19. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214
20. Coleman, D. L. (1982) Diabetes-obesity syndromes in mice. Diabetes 31, 1-6
21. Hummel, K. P., Dickie, M. M., and Coleman, D. L. (1966) Diabetes, a new mutation in the mouse. Science 153, 1127-1128
22. Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M., Skinner, M. E., Lombard, D. B., and Zhao, Y. (2013) SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell 50, 919-930
23. Mi, H., Muruganujan, A., Casagrande, J. T., and Thomas, P. D. (2013) Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551-1566
24. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
25. Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., and Jensen, L. J. (2013) STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815
26. Bader, G. D., and Hogue, C. W. (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4, 2
27. Glaser, B., Kesavan, P., Heyman, M., Davis, E., Cuesta, A., Buchs, A., Stanley, C. A., Thornton, P. S., Permutt, M. A., Matschinsky, F. M., and Herold, K. C. (1998) Familial hyperinsulinism caused by an activating glucokinase mutation. N. Engl. J. Med. 338, 226-230
28. Froguel, P., Vaxillaire, M., Sun, F., Velho, G., Zouali, H., Butel, M. O., Lesage, S., Vionnet, N., Clement, K., Fougerousse, F., Tanizawa, Y., Weissenbach, J., Beckmann, J. S., Lathrop, G. M., Passa, P., Permutt, M. A., and Cohen, D. (1992) Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356, 162-164
29. Clore, J. N., Stillman, J., and Sugerman, H. (2000) Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 49, 969-974
30. Massillon, D., Barzilai, N., Hawkins, M., Prus-Wertheimer, D., and Rossetti, L. (1997) Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes 46, 153-157
31. Ristow, M., Vorgerd, M., Mohlig, M., Schatz, H., and Pfeiffer, A. (1997) Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance. J. Clin. Invest. 100, 2833-2841
32. Martin, W. H., Hoover, D. J., Armento, S. J., Stock, I. A., McPherson, R. K., Danley, D. E., Stevenson, R. W., Barrett, E. J., and Treadway, J. L. (1998) Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo. Proc. Natl. Acad. Sci. U.S.A. 95, 1776-1781
33. Yu, J., Sadhukhan, S., Noriega, L. G., Moullan, N., He, B., Weiss, R. S., Lin, H., Schoonjans, K., and Auwerx, J. (2013) Metabolic characterization of a Sirt5 deficient mouse model. Sci. Rep. 3, 2806
34. Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., Li, Y., Shi, J., An, W., Hancock, S. M., He, F., Qin, L., Chin, J., Yang, P., Chen, X., Lei, Q., Xiong, Y., and Guan, K. L. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004
35. Kosanam, H., Thai, K., Zhang, Y., Advani, A., Connelly, K. A., Diamandis, E. P., and Gilbert, R. E. (2014) Diabetes induces lysine acetylation of intermediary metabolism enzymes in the kidney. Diabetes 63, 2432-2439
36. Tan, M., Peng, C., Anderson, K. A., Chhoy, P., Xie, Z., Dai, L., Park, J., Chen, Y., Huang, H., Zhang, Y., Ro, J., Wagner, G. R., Green, M. F., Madsen, A. S., Schmiesing, J., Peterson, B. S., Xu, G., Ilkayeva, O. R., Muehlbauer, M. J., Braulke, T., Muhlhausen, C., Backos, D. S., Olsen, C. A., McGuire, P. J., Pletcher, S. D., Lombard, D. B., Hirschey, M. D., and Zhao, Y. (2014) Lysine glutarylation is a protein post-translational modification regulated by SIRT5. Cell Metab. 19, 605-617